AST Clinical Investigation

Blood glucose monitoring system are tested in the alternative site to validate the accuracy of the blood glucose.

Completed

Looking for future studies?

Key information

Conditions

Diabetes Diabetes Mellitus Endocrine System Diseases Glucose Metabolism Disorders Metabolic Diseases Nutritional and Metabolic Diseases

Age range

21 year–78 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Tianjin Hexi Ruijing metabolism hospital

Tianjin, Tianjin Municipality, China

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

people ( disbetes people)with at least 8 hours of limosis

Exclusion criteria

After meal(when doing the test)
take Hypoglycemic Drugs(when doing the test)
with insulin(when doing the test)
after strenuous exercise(when doing the test)
Pregnant women
neonates
patients in a hyperglycemic-hyperosmolur state, with or without ketosis.
patients who are dehydrated, hypertensive, hypotensive or in shock.

Treatment and study plan

Blood Glucose Monitor

Device

Blood glucose monitor is used to monitor the blood glucose level of the human-being

Other names: Andon blood glucose monitor

Primary outcomes

blood glucose value

Time frame: 5 seconds

Sponsors and collaborators

Lead sponsor

Andon Medical Co.,Ltd

Industry

Registry information

Important dates

Study start: 2010
Primary completion: 2010
Study completion: 2010
First posted: Dec 30, 2010
Registry last updated: Dec 30, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed